Flupirtine as Oral Treatment in Multiple Sclerosis

Summary

Flupirtine, a non-opioid analgesic drug, that has been shown to have additional neuroprotective functions, is given twice daily as an oral medication in patients with relapsing remitting multiple sclerosis over a period of 12 months. Neuroprotection is assessed by magnetic resonance imaging, magnetic resonance spectroscopy, optical coherence tomography, and clinical examination.

Timeline

Start

2007-12

Primary completion

2012-11

Completion

2012-11

Drugs

Indications